TennisEdge's AI model finds no betting value in F. Cobolli vs R. A. Burruchaga (Umag on 2026-07-15) — the market is efficient, with F. Cobolli favoured at 1.39.
═══ F. Cobolli vs R. A. Burruchaga — Umag (clay) ═══
MODELS vs MARKET
Odds: Cobolli 1.39 (69.7% implied) | Burruchaga 3.19 (31.3%)
ELO 68.3% A | ML 73.7% A | Model 68.3% A
Value pick B, edge +1.4% — noise-level. Full model+market consensus.
RECENT FORM (last 5 shown)
Cobolli (A):
07-08 Wimbledon QF L vs Fery (1766) 4-6 6-7 0-6 GRIND
07-06 Wimbledon R16 W vs De Minaur (1907) 5-7 6(4)-7 3-6 GRIND vs Elite
07-04 Wimbledon R32 W vs Khachanov (1788) 5 sets GRIND vs Strong
07-02 Wimbledon R64 W vs Duckworth (1571) 4 sets, 2 TBs GRIND
07-01 Wimbledon R128 W vs Navone (1441) 4 sets, 2 TBs GRIND
Deeper: FO finalist (lost Zverev 06-07), wins over Medvedev/Zverev spring clay.
Elite-quality wins, but nearly every recent win is GRIND-class.
Burruchaga (B):
07-14 Umag R16 W vs Cecchinato (1699) 6-1 6-4 DOM vs Strong
07-07 Braunschweig CH L vs Schoenhaus (1630)
06-30 Wimbledon R128 L vs De Minaur (1867)
06-23 Eastbourne R16 L vs Fery (1687)
05-28 French Open R64 L vs Auger-Aliassime (1806)
Overall ~5-8 in sample; 1 win in last 5 before yesterday. Poor form.
FATIGUE
Cobolli: 5 matches / 15 sets / 793 min in 14d, but 7 rest days since Wimbledon QF.
Burruchaga: 3 matches / 9 sets / 297 min in 14d, played yesterday.
Raw court-time diff huge (>60min → A disadvantaged), but a full week off
largely resets it. Real concern is grass→clay transition + Umag debut cold open.
NARRATIVE
Let-down: none (FO Final 38d ago, outside window; Wimbledon QF loss not a Final).
Venue: Burruchaga 1-0 at Umag (yesterday); Cobolli no Umag history.
Title recency: none for either.
VERDICT — PASS
ELO and ML both agree with the market (ML even a touch higher on A).
The only dog angle — Cobolli's heavy Wimbledon workload + surface switch vs a
match-tough local dog — is half-mitigated by 7 rest days and fully undercut by
Burruchaga's poor underlying form (Challenger loss to a 1630 last week).
1.4% nominal edge with no qualitative validation. No alt markets priced.